A detailed history of Us Bancorp \De\ transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 2,455 shares of RVMD stock, worth $106,276. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,455
Previous 2,951 16.81%
Holding current value
$106,276
Previous $114,000 2.63%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$36.92 - $47.94 $18,312 - $23,778
-496 Reduced 16.81%
2,455 $111,000
Q2 2024

Aug 06, 2024

BUY
$30.14 - $40.68 $5,123 - $6,915
170 Added 6.11%
2,951 $114,000
Q1 2024

May 07, 2024

BUY
$26.56 - $33.55 $13,864 - $17,513
522 Added 23.11%
2,781 $89,000
Q4 2023

Feb 09, 2024

BUY
$18.35 - $34.12 $16,037 - $29,820
874 Added 63.1%
2,259 $64,000
Q3 2023

Nov 03, 2023

SELL
$25.17 - $35.05 $4,782 - $6,659
-190 Reduced 12.06%
1,385 $38,000
Q2 2023

Aug 09, 2023

BUY
$20.28 - $27.0 $12,938 - $17,226
638 Added 68.09%
1,575 $42,000
Q1 2023

May 09, 2023

BUY
$20.76 - $30.09 $11,874 - $17,211
572 Added 156.71%
937 $20,000
Q4 2022

Feb 13, 2023

SELL
$17.68 - $25.53 $5,410 - $7,812
-306 Reduced 45.6%
365 $8,000
Q3 2022

Oct 27, 2022

BUY
$17.46 - $26.0 $3,492 - $5,200
200 Added 42.46%
671 $13,000
Q2 2022

Aug 01, 2022

SELL
$14.54 - $27.17 $7,037 - $13,150
-484 Reduced 50.68%
471 $9,000
Q1 2022

May 11, 2022

BUY
$17.31 - $26.4 $6,145 - $9,372
355 Added 59.17%
955 $25,000
Q4 2021

Feb 11, 2022

BUY
$24.35 - $33.7 $2,581 - $3,572
106 Added 21.46%
600 $15,000
Q3 2021

Nov 10, 2021

BUY
$23.95 - $33.41 $1,700 - $2,372
71 Added 16.78%
494 $13,000
Q2 2021

Aug 05, 2021

BUY
$29.0 - $47.44 $10,411 - $17,030
359 Added 560.94%
423 $14,000
Q1 2021

Apr 28, 2021

BUY
$37.21 - $54.43 $2,381 - $3,483
64 New
64 $3,000
Q4 2020

Feb 04, 2021

SELL
$30.19 - $45.49 $18,114 - $27,294
-600 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$22.61 - $34.8 $13,566 - $20,880
600 New
600 $21,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.